BIONECT CREAM

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 99 report with the FDA on 2014-12-15 for BIONECT CREAM manufactured by Fidia Farmaceutici Spa,.

Event Text Entries

[5365120] This spontaneous report was received from a consumer via phone on (b)(6) 2012. The consumer reports she started using the product on friday, (b)(6) 2012, applying it to her vulva twice daily for a vaginal cut. About 8 hours after the first dose, she broke out into hives and also developed chest pain, back pain, and wheezing. She continued to use the product on (b)(6) 2012. In the middle of the night on (b)(6) 2012 she decided to go to the local emergency room. While in the emergency room she received an albuterol nebulizer. She is currently on prednisone and an unk antihistamine which was prescribed by the emergency room physician. The hives have not healed completely, but her other symptoms have dissipated. Mfr ref# 9610200-2014-00016.
Patient Sequence No: 1, Text Type: D, B5


[12689178] The info contained in this report is based on self-reported statements provided to the manufacturer during a telephone interview. These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, info contained in this report does not and can not form the basis for a determination of whether the reported clinical effects are causally related or associated with an exposure to the product identified in the telephone interview. The info provided in this report has not been medically verified via confirmation with the patient's physicians or by the provision of patient medical records. When considering the body of regulatory data and post-marketing data as well as the weight of scientific peer reviewed evidence on topically applied hyaluronate containing product such a causal relationship between the use of this type of device and the development of the adverse effects reported in this case cannot be definitively established. When evaluating a patient for a potential hypersensitivity (allergic) reaction, a clinical practitioner must consider several potential environmental etiologies as well as any foods, beverages, medications, or dietary supplements the patient had been taking just prior to the onset of symptoms. Definitive causality cannot be applied to any one compound or agent without verification.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number3005536974-2012-00002
MDR Report Key4387818
Report Source99
Date Received2014-12-15
Date of Report2012-02-02
Date of Event2012-01-27
Date Facility Aware2011-12-20
Report Date2014-11-18
Date Reported to FDA2012-02-08
Date Reported to Mfgr2014-11-18
Date Added to Maude2015-01-08
Event Key0
Report Source CodeDistributor report
Manufacturer LinkN
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer Street140 E BAY STREET SUITE C
Manufacturer CityCHARLESTON SC 29401
Manufacturer CountryUS
Manufacturer Postal29401
Manufacturer G1JSJ PHARMACEUTICALS
Manufacturer Street140 E BAY STREET SUITE C
Manufacturer CityCHARLESTON SC 29401
Manufacturer CountryUS
Manufacturer Postal Code29401
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameBIONECT CREAM
Generic NameHYALURONIC ACID SODIUM SALT
Product CodeMGQ
Date Received2014-12-15
Lot Number016000
ID Number68712-008-03
Device Expiration Date2012-11-01
OperatorLAY USER/PATIENT
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerFIDIA FARMACEUTICI SPA,
Manufacturer AddressVIA PONTE DELLA FABBRICA 3/A ABANO TERME (PD) 35031 IT 35031


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2014-12-15

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.